No credit card. No commitment.
5000+ G2 reviews
NATA - Nucleic Acid Therapy Accelerator
Research
EnglandNATA - Nucleic Acid Therapy Accelerator
ResearchEngland
EmployeesNATA - Nucleic Acid Therapy Accelerator's financial review
Employees
21
NATA - Nucleic Acid Therapy Accelerator information
The Nucleic Acid Therapy Accelerator (NATA) is a new national research initiative with a mission to accelerate the development of nucleic acid therapeutics, while firmly anchoring the nucleic acid (NA) therapy industry in the UK for many years to come. The NATA will be at the Harwell Science and Innovation Campus, at the heart of a growing Life Health Cluster. It will benefit from and contribute t...
The Nucleic Acid Therapy Accelerator (NATA) is a new national research initiative with a mission to accelerate the development of nucleic acid therapeutics, while firmly anchoring the nucleic acid (NA) therapy industry in the UK for many years to come. The NATA will be at the Harwell Science and Innovation Campus, at the heart of a growing Life Health Cluster. It will benefit from and contribute to the campus' world-class scientific talent, ecosystem and related facilities, including the Research Complex at Harwell and the new Rosalind Franklin Institute.
NATA - Nucleic Acid Therapy Accelerator industries
Research
Research services
NATA - Nucleic Acid Therapy Accelerator's financial review
Employees
21
Employee Metrics
Technologies
Email Providers
Other
Other
Tag Management
Other
Load Balancers
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
